Three cases (two patients) of large vasoproliferative retinal tumor treatment by an original method, which includes intraoperative non-contact transscleral thermotherapy and subsequent transpupillary thermotherapy, are described. Positive anatomical results were achieved in all three cases.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Uveal metastasis: clinical characteristics, treatment, and prognostic factors in a cohort of 161 patients in China.
Can J Ophthalmol
January 2025
Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology &Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Objective: To investigate the clinical and prognostic features of uveal metastasis in a Chinese population and compare these features across different primary cancers.
Design: Retrospective cross-sectional study.
Participants: 161 patients with uveal metastasis at Beijing Tongren Hospital.
Malignant Transformation of a Choroidal Nevus.
Cureus
December 2024
Department of Ophthalmology, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, CHN.
Choroidal nevus is the most common intraocular tumor, and most cases are benign and have no symptoms. However, choroidal nevus carries a low risk for transformation into melanoma, which is a highly aggressive and deadly cancer. In this case report, we present a male patient with blurred vision in his left eye for six months.
View Article and Find Full Text PDFClinical Features and Treatment Outcomes of Choroidal Osteoma in Asian Indians (80 Patients).
Retina
November 2024
Anant Bajaj Retina Institute, LV Prasad Eye Institute, Hyderabad, India.
Article Synopsis
- The study examined 80 Indian patients with choroidal osteoma, focusing on demographic and clinical characteristics as well as treatment outcomes.
- Most patients were female (61%), with the majority in their second decade of life; various associated complications like choroidal neovascularization (CNV) were noted in 40% of eyes.
- Treatment methods included anti-VEGF therapy for CNV and other procedures, with mean best corrected visual acuity improving slightly over a follow-up period, indicating the need for ongoing monitoring despite the generally benign nature of the condition.
Management of circumscribed choroidal hemangioma at a tertiary care center.
Int Ophthalmol
July 2024
Ocular Oncology Service, Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey.
Purpose: To review long-term outcomes of circumscribed choroidal hemangioma (CCH).
Methods: Hospital charts of all CCH cases diagnosed from 2008 to 2019 were retrospectively reviewed.
Results: All 172 patients were managed with either observation, transpupillary thermotherapy, argon laser photocoagulation, photodynamic therapy, plaque brachytherapy or stereotactic radiosurgery.
Comparison of the therapeutic effects of photodynamic therapy, transpupillary thermotherapy, and their combination on circumscribed choroidal haemangioma.
Photodiagnosis Photodyn Ther
August 2024
Department of Dermatology, People's Liberation Army Air Force Special Medical Center, Beijing 100142, China. Electronic address:
Objective: To characterize the clinical and imaging features of circumscribed choroidal hemangioma (CCH), and to evaluate individualized treatment efficiency of photodynamic therapy (PDT), transpupillary thermotherapy (TTT), or their combination, followed by retrobulbar injection of betamethasone on CCH resolvement.
Methods: Forty-nine patients with CCHs who underwent PDT, TTT or PDT+TTT treatments were retrospectively analyzed. Their treatment efficacy was compared by analyzing the change of best corrected visual acuity (BCVA), subretinal fluid (SRF) and CCH lesion characteristics.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!